Vesalio Announces Initial Use of Its Uniquely Designed and FDA-Approved NeVa VS Device for Neurovascular Vasospasm in the United States
Vesalio announces the successful initial use of its NeVa VS device in the United States for the treatment of post-aneurysmal subarachnoid hemorrhage (aSAH)...
Source: pr.com